Compumedics Limited (ASX:CMP)
Australia · Delayed Price · Currency is AUD 0.2300
-0.0050 (-2.13%)
Sep 17, 2026, 2:56 PM AEST
Compumedics Market Cap
Compumedics has a market cap or net worth of 45.95 million as of September 17, 2026. Its market cap has decreased by -17.50% in one year.
Market Cap
45.95M
Enterprise Value
53.91M
Revenue
61.88M
Ranking
n/a
PE Ratio
230.00
Stock Price
0.23
ChartMarket Cap Chart
Since December 22, 2000, Compumedics's market cap has decreased from 71.37M to 45.95M, a decrease of -35.63%. That is a compound annual growth rate of -1.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 45.95M | -31.34% |
| Dec 31, 2025 | 66.92M | 31.50% |
| Dec 31, 2024 | 50.89M | 2.59% |
| Dec 29, 2023 | 49.61M | 40.00% |
| Dec 29, 2022 | 35.43M | -45.95% |
| Dec 31, 2021 | 65.55M | -26.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lumos Diagnostics Holdings | 103.93M |
| Saluda Medical | 102.07M |
| SomnoMed | 73.62M |
| Cyclopharm | 62.87M |
| Epiminder | 60.67M |
| Cleo Diagnostics | 42.50M |
| HeraMED | 38.24M |
| OncoSil Medical | 37.25M |